BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 18778316)

  • 1. Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation.
    Frey AD; Karg SR; Kallio PT
    Plant Biotechnol J; 2009 Jan; 7(1):33-48. PubMed ID: 18778316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of N-linked xylose and fucose by expression of rat beta1,4-N-acetylglucosaminyltransferase III in tobacco BY-2 cells depends on Golgi enzyme localization domain and genetic elements used for expression.
    Karg SR; Frey AD; Kallio PT
    J Biotechnol; 2010 Mar; 146(1-2):54-65. PubMed ID: 20083147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III.
    Rouwendal GJ; Wuhrer M; Florack DE; Koeleman CA; Deelder AM; Bakker H; Stoopen GM; van Die I; Helsper JP; Hokke CH; Bosch D
    Glycobiology; 2007 Mar; 17(3):334-44. PubMed ID: 17179169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose.
    Strasser R; Altmann F; Mach L; Glössl J; Steinkellner H
    FEBS Lett; 2004 Mar; 561(1-3):132-6. PubMed ID: 15013764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of fucose residues in plant N-glycans by repression of the GDP-mannose 4,6-dehydratase gene using virus-induced gene silencing and RNA interference.
    Matsuo K; Matsumura T
    Plant Biotechnol J; 2011 Feb; 9(2):264-81. PubMed ID: 20731789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.
    Ferrara C; Brünker P; Suter T; Moser S; Püntener U; Umaña P
    Biotechnol Bioeng; 2006 Apr; 93(5):851-61. PubMed ID: 16435400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants.
    Triguero A; Cabrera G; Royle L; Harvey DJ; Rudd PM; Dwek RA; Bardor M; Lerouge P; Cremata JA
    Anal Biochem; 2010 May; 400(2):173-83. PubMed ID: 20109437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of enzymatically active human alpha-L-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds.
    Downing WL; Galpin JD; Clemens S; Lauzon SM; Samuels AL; Pidkowich MS; Clarke LA; Kermode AR
    Plant Biotechnol J; 2006 Mar; 4(2):169-81. PubMed ID: 17177794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.
    Schähs M; Strasser R; Stadlmann J; Kunert R; Rademacher T; Steinkellner H
    Plant Biotechnol J; 2007 Sep; 5(5):657-63. PubMed ID: 17678502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants.
    Chen M; Liu X; Wang Z; Song J; Qi Q; Wang PG
    Med Res Rev; 2005 May; 25(3):343-60. PubMed ID: 15499575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and characterization of Arabidopsis thaliana Golgi alpha-mannosidase II, a key enzyme in the formation of complex N-glycans in plants.
    Strasser R; Schoberer J; Jin C; Glössl J; Mach L; Steinkellner H
    Plant J; 2006 Mar; 45(5):789-803. PubMed ID: 16460512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Lewis X epitopes on plant N-glycans.
    Rouwendal GJ; Florack DE; Hesselink T; Cordewener JH; Helsper JP; Bosch D
    Carbohydr Res; 2009 Aug; 344(12):1487-93. PubMed ID: 19515362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of recombinant human granulocyte macrophage-colony stimulating factor in rice cell suspension culture with a human-like N-glycan structure.
    Shin YJ; Chong YJ; Yang MS; Kwon TH
    Plant Biotechnol J; 2011 Dec; 9(9):1109-19. PubMed ID: 21801300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled glycosylation of therapeutic antibodies in plants.
    Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
    Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyco-engineering of moss lacking plant-specific sugar residues.
    Huether CM; Lienhart O; Baur A; Stemmer C; Gorr G; Reski R; Decker EL
    Plant Biol (Stuttg); 2005 May; 7(3):292-9. PubMed ID: 15912449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans.
    Triguero A; Cabrera G; Cremata JA; Yuen CT; Wheeler J; Ramírez NI
    Plant Biotechnol J; 2005 Jul; 3(4):449-57. PubMed ID: 17173632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues.
    Sriraman R; Bardor M; Sack M; Vaquero C; Faye L; Fischer R; Finnern R; Lerouge P
    Plant Biotechnol J; 2004 Jul; 2(4):279-87. PubMed ID: 17134389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
    Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
    Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
    Strasser R; Stadlmann J; Schähs M; Stiegler G; Quendler H; Mach L; Glössl J; Weterings K; Pabst M; Steinkellner H
    Plant Biotechnol J; 2008 May; 6(4):392-402. PubMed ID: 18346095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering.
    Schuster M; Umana P; Ferrara C; Brünker P; Gerdes C; Waxenecker G; Wiederkum S; Schwager C; Loibner H; Himmler G; Mudde GC
    Cancer Res; 2005 Sep; 65(17):7934-41. PubMed ID: 16140965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.